A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Verona Pharma Plc ADR’s current trading price is -32.42% away from its 52-week high, while its distance from the 52-week low is 36.01%. The stock’s price range for this time frame has been between $11.83 and $23.81. The trading volume of the company’s shares in the Healthcare reached around 0.31 million for the day, which was evidently lower than the average daily volume of 0.53 million over the last three months.
The stock market performance of Verona Pharma Plc ADR has been fairly unsteady. Over the last year, the company’s stock hit its highest at $23.81 on 05/10/23, while the lowest price during the same time frame was $11.83, recorded on 10/26/23.
How Financial Performance Impacts Market Capitalization
Verona Pharma Plc ADR (VRNA) has experienced a quarterly decline of -21.40% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.29B and boasts a workforce of 79 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 16.51, with a change in price of +1.15. Similarly, Verona Pharma Plc ADR recorded 511,661 in trading volume during the last 100 days, posting a change of +7.70%.
How VRNA’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for VRNA stands at 0.21. Similarly, the long-term debt-to-equity ratio is also 0.20.
VRNA Stock Stochastic Average
The raw stochastic average for Verona Pharma Plc ADR over the last 50 days is presently at 23.56%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 28.99%. Further, the company’s Stochastic %K and %D values for the last 20 days were 33.53% and 29.58%, respectively.
VRNA Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Year to date metric has recorded a loss of -19.06%.However, over the last six months, we can see a stronger performance of -5.02%. Over the last 30 days, the price of VRNA has leaped by -6.78%. And in the last five days, it has surged by 0.88%.
